Literature DB >> 6144463

A cross-national comparison of anti-anxiety/sedative drug use.

M B Balter, D I Manheimer, G D Mellinger, E H Uhlenhuth.   

Abstract

Findings are reported from a 1981 cross-national survey of the use of anti-anxiety/sedative medications by adults in the general population of the United States and 10 Western European countries. Representative national samples in the 11 countries were asked a standard set of questions about their use of these medications during the preceding 12 months. Data were obtained by personal interview in the course of a household visit. The number of persons interviewed ranged from 1486 to 2018. The data provide comparable estimates of past-year prevalence of use-the proportion of the population who took these medications one or more times, and duration of use-and the proportion of the population who took these medications daily for various lengths of time. Rates for past-year prevalence of use varied from 17.6% in Belgium to 7.4% in the Netherlands. The United States at 12.9% was in the middle of the distribution. There was wide variation among countries in the prevalence of long-term and short-term use, but regular daily use for 3 months or less was the predominant pattern in 10 of the 11 countries surveyed. Past-year prevalence rates were much higher for women than for men in every country surveyed. At the national level, the data show that simple past-year prevalence rates and durational parameters of use are relatively independent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144463     DOI: 10.1185/03007998409109541

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  36 in total

Review 1.  Is there still a role for benzodiazepines in general practice?

Authors:  M B King
Journal:  Br J Gen Pract       Date:  1992-05       Impact factor: 5.386

2.  Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France.

Authors:  Myriam Khlat; Catherine Sermet; Annick Le Pape
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians' attitudes toward benzodiazepine prescribing.

Authors:  Sibyl Anthierens; Inge Pasteels; Hilde Habraken; Pascale Steinberg; Tom Declercq; Thierry Christiaens
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

4.  On the differences in psychotropic drug use between the three major urban areas in Sweden.

Authors:  A Wessling; U Bergman; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Sedatives and hypnotics in Stockholm: social factors and kinds of use.

Authors:  G Blennow; A Romelsjö; H Leifman; A Leifman; G Karlsson
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

6.  Drug treatment of obsessive-compulsive disorder.

Authors:  P T Lelliott; W O Monteiro
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

Review 7.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  First benzodiazepine prescriptions: qualitative study of patients' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Myriam Deveugele; Jan De Maeseneer; Thierry Christiaens
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

9.  Sex differences among recipients of benzodiazepines in Dutch general practice.

Authors:  F W van der Waals; J Mohrs; M Foets
Journal:  BMJ       Date:  1993-08-07

10.  A population-wide profile of prescription drug use in Saskatchewan, 1989.

Authors:  K Quinn; M J Baker; B Evans
Journal:  CMAJ       Date:  1992-06-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.